Masao Ogura

1.3k total citations
77 papers, 696 citations indexed

About

Masao Ogura is a scholar working on Nephrology, Pediatrics, Perinatology and Child Health and Pulmonary and Respiratory Medicine. According to data from OpenAlex, Masao Ogura has authored 77 papers receiving a total of 696 indexed citations (citations by other indexed papers that have themselves been cited), including 38 papers in Nephrology, 17 papers in Pediatrics, Perinatology and Child Health and 17 papers in Pulmonary and Respiratory Medicine. Recurrent topics in Masao Ogura's work include Renal Diseases and Glomerulopathies (32 papers), Pediatric Urology and Nephrology Studies (13 papers) and Autoimmune Bullous Skin Diseases (8 papers). Masao Ogura is often cited by papers focused on Renal Diseases and Glomerulopathies (32 papers), Pediatric Urology and Nephrology Studies (13 papers) and Autoimmune Bullous Skin Diseases (8 papers). Masao Ogura collaborates with scholars based in Japan, United States and United Kingdom. Masao Ogura's co-authors include Koichi Kamei, Shuichi Ito, Mai Sato, Kazumoto Iijima, Kenji Ishikura, Tomohiro Udagawa, Kentaro Matsuoka, Mayumi Sako, Takuya Fujimaru and Ken Saida and has published in prestigious journals such as PLoS ONE, The Journal of Pediatrics and Journal of Applied Crystallography.

In The Last Decade

Masao Ogura

71 papers receiving 683 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Masao Ogura Japan 16 441 172 161 146 113 77 696
Marianne Delville France 13 313 0.7× 72 0.4× 79 0.5× 100 0.7× 113 1.0× 20 670
Dominique Desvaux France 22 332 0.8× 98 0.6× 47 0.3× 75 0.5× 191 1.7× 43 1.0k
Arnaud Garnier France 14 632 1.4× 98 0.6× 262 1.6× 161 1.1× 75 0.7× 29 1.1k
Jorge Martínez-Ara Spain 12 352 0.8× 95 0.6× 112 0.7× 51 0.3× 77 0.7× 27 695
Anissa Moktefi France 13 191 0.4× 61 0.4× 36 0.2× 53 0.4× 90 0.8× 46 493
Mathieu Jablonski France 12 476 1.1× 66 0.4× 258 1.6× 104 0.7× 87 0.8× 16 990
Jörg Beimler Germany 19 202 0.5× 27 0.2× 152 0.9× 113 0.8× 92 0.8× 45 975
Atif Awan Ireland 14 278 0.6× 40 0.2× 97 0.6× 56 0.4× 111 1.0× 46 645
Nathalie Morel France 17 166 0.4× 79 0.5× 234 1.5× 45 0.3× 46 0.4× 44 997
Christelle Barbet France 12 293 0.7× 25 0.1× 86 0.5× 47 0.3× 98 0.9× 39 622

Countries citing papers authored by Masao Ogura

Since Specialization
Citations

This map shows the geographic impact of Masao Ogura's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Masao Ogura with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Masao Ogura more than expected).

Fields of papers citing papers by Masao Ogura

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Masao Ogura. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Masao Ogura. The network helps show where Masao Ogura may publish in the future.

Co-authorship network of co-authors of Masao Ogura

This figure shows the co-authorship network connecting the top 25 collaborators of Masao Ogura. A scholar is included among the top collaborators of Masao Ogura based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Masao Ogura. Masao Ogura is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Kaneda, Tomoya, et al.. (2023). Complications and prognosis of patients diagnosed with autosomal recessive polycystic kidney disease in neonatal period. CEN Case Reports. 13(3). 181–187. 1 indexed citations
3.
Ogura, Masao, et al.. (2021). Tocilizumab for juvenile Takayasu arteritis complicated with acute heart failure at onset. Modern Rheumatology Case Reports. 6(2). 226–229.
4.
Kamei, Koichi, Isao Miyairi, Kensuke Shoji, et al.. (2021). Live attenuated vaccines under immunosuppressive agents or biological agents: survey and clinical data from Japan. European Journal of Pediatrics. 180(6). 1847–1854. 2 indexed citations
5.
Kamei, Koichi, Masao Ogura, Mai Sato, et al.. (2021). Correction to: Risk factors for post-nephrectomy hypotension in pediatric patients. Pediatric Nephrology. 36(11). 3805–3806. 1 indexed citations
6.
Ubara, Yoshifumi, Takehiko Kawaguchi, Tasuku Nagasawa, et al.. (2021). Correction to: Kidney biopsy guidebook 2020 in Japan. Clinical and Experimental Nephrology. 25(10). 1161–1161. 1 indexed citations
7.
Ubara, Yoshifumi, Takehiko Kawaguchi, Tasuku Nagasawa, et al.. (2021). Kidney biopsy guidebook 2020 in Japan. Clinical and Experimental Nephrology. 25(4). 325–364. 24 indexed citations
8.
Sato, Mai, et al.. (2021). Cholelithiasis in infants with congenital nephrotic syndrome of the Finnish type. Pediatric Nephrology. 36(11). 3795–3798. 1 indexed citations
9.
Sakamoto, Atsushi, Masao Ogura, Atsushi Hattori, et al.. (2021). Lupus anticoagulant hypoprothrombinemia syndrome associated with bilateral adrenal haemorrhage in a child: early diagnosis and intervention. Thrombosis Journal. 19(1). 19–19. 10 indexed citations
10.
Sato, Mai, et al.. (2020). Two cases of idiopathic steroid-resistant nephrotic syndrome complicated with thrombotic microangiopathy. BMC Nephrology. 21(1). 323–323. 3 indexed citations
11.
Kamei, Koichi, Mai Sato, Masao Ogura, et al.. (2020). Prophylactic rituximab administration in children with complicated nephrotic syndrome. Pediatric Nephrology. 36(3). 611–619. 5 indexed citations
12.
Ishimori, Shingo, Koichi Kamei, Takashi Ando, et al.. (2020). Influenza virus vaccination in children with nephrotic syndrome: insignificant risk of relapse. Clinical and Experimental Nephrology. 24(11). 1069–1076. 9 indexed citations
13.
Kamei, Koichi, Riku Hamada, Hiroshi Hataya, et al.. (2019). Detailed clinical manifestations at onset and prognosis of neonatal-onset Denys–Drash syndrome and congenital nephrotic syndrome of the Finnish type. Clinical and Experimental Nephrology. 23(8). 1058–1065. 15 indexed citations
14.
Sato, Mai, Tetsuji Kaneko, Masao Ogura, et al.. (2018). Favorable Kidney Function in Pediatric Liver Transplant Recipients: Results of a Single-center Cohort Study. Transplantation. 103(8). 1655–1662. 3 indexed citations
15.
Kamei, Koichi, Masao Ogura, Mai Sato, et al.. (2015). Risk factors for relapse and long-term outcome in steroid-dependent nephrotic syndrome treated with rituximab. Pediatric Nephrology. 31(1). 89–95. 27 indexed citations
16.
Kamei, Koichi, Mari Okada, Mai Sato, et al.. (2014). Rituximab treatment combined with methylprednisolone pulse therapy and immunosuppressants for childhood steroid-resistant nephrotic syndrome. Pediatric Nephrology. 29(7). 1181–1187. 34 indexed citations
17.
Sato, Mai, Shuichi Ito, Masao Ogura, et al.. (2012). Atypical Pneumocystis jiroveci pneumonia with multiple nodular granulomas after rituximab for refractory nephrotic syndrome. Pediatric Nephrology. 28(1). 145–149. 37 indexed citations
18.
Ito, Shuichi, Koichi Kamei, Masao Ogura, et al.. (2012). Survey of rituximab treatment for childhood-onset refractory nephrotic syndrome. Pediatric Nephrology. 28(2). 257–264. 55 indexed citations
19.
Udagawa, Tomohiro, Koichi Kamei, Masao Ogura, et al.. (2011). Sequential liver–kidney transplantation in a boy with congenital hepatic fibrosis and nephronophthisis from a living donor. Pediatric Transplantation. 16(7). E275–80. 11 indexed citations
20.
Kaito, Hiroshi, Koichi Kamei, Eriko Kikuchi, et al.. (2009). Successful treatment of collapsing focal segmental glomerulosclerosis with a combination of rituximab, steroids and ciclosporin. Pediatric Nephrology. 25(5). 957–959. 18 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Rankless by CCL
2026